Brecon appoints new Head of Clinical Trials Services

Leading pharmaceutical outsource services provider Brecon Pharmaceuticals has appointed Dr Susan Miles as Head of Clinical Trials Services.



Sue Miles is a graduate from Cambridge University with a PhD from the Faculty of Medicine at Edinburgh University. She was previously Chief Executive Officer of Quantum Research UK, which provides electrocardiography, respiratory and blood pressure monitoring support for the clinical trials industry.

Commenting on the new appointment, Brecon’s Chief Executive John Bath said, “Clinical Trials Services has become a major area of business growth for us. We already have a well-respected presence in this market and offer excellent quality, service and value for our customers. We are delighted that we have someone with Sue’s extensive market experience to head up the team.”

Sue Miles believes Brecon is well placed to capitalise on the many opportunities that will result from the introduction of the new EC Clinical Trials Directive. She said, “I am looking forward to supporting Brecon in the development of its Clinical Trials Services. The new EC Directive will make choosing a clinical trial service provider an even more crucial decision and I believe Brecon is well placed to meet customers’ demands.”

19 April 2021

Back to Archive 2004 Article Index